DOCSLIB.ORG

Analysis of Multiprotein Complexes in the Mammalian Retina

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Analysis of Multiprotein Complexes in the Mammalian Retina Analysis of Multiprotein Complexes in the Mammalian Retina Monika Viktoria Beer Dissertation an der Fakultät für Biologie der Ludwig-Maximilians-Universität München Vorgelegt von Monika Viktoria Beer aus Fürstenfeldbruck München, den 12. August 2008 Cover: Immunohistochemistry of porcine retina sections with anti-Rac1 antibody Erklärung: Hiermit erkläre ich, dass ich die vorliegende Dissertation selbständig und ohne unerlaubte Hilfe angefertigt habe. München, 12. August 2008 Dissertation eingereicht: 12. August 2008 Tag der mündlichen Prüfung: 19. Dezember 2008 Erstgutachter: Prof. Dr. Lutz Eichacker Zweitgutachter: Prof. Dr. Hugo Scheer Sondergutachter: Dr. Marius Ueffing Monika Beer, Dissertation Table of Contents TABLE OF CONTENTS A. ABBREVIATIONS………………………………………………………… 1 B. SUMMARY………………………………………………………………..... 5 C. ZUSAMMENFASSUNG…………………………………………………… .8 D. INTRODUCTION………………………………………………………….. 12 1. THE MAMMALIAN RETINA…………………………………………………….......... 12 1.1 Structure and function……………………………………………………………….. 12 1.1.1 The retinal pigment epithelium……………………………………………………… 13 1.1.2 The photoreceptors…………………………………………………………………... 14 1.1.3 The other retinal cell types…………………………………………………………... 15 1.1.3.1 Other neurons……………………………………………………………………… 15 1.1.3.1.1 Bipolar cells…………………………………………………………………… 15 1.1.3.1.2 Horizontal cells……………………………………………………………….. 16 1.1.3.1.3 Amacrine cells………………………………………………………………… 16 1.1.3.1.4 Ganglion cells…………………………………………………………………. 17 1.1.3.1.5 The interplexiform cells……………………………………………………….. 17 1.1.3.2 Retinal glial cells…………………………………………………………………... 17 1.1.3.2.1 Müller glial cells (MC)………………………………………………………... 17 1.1.3.2.2 Astrocytes……………………………………………………………………... 18 1.1.4 Murine retina………………………………………………………………………… 18 1.1.5 Porcine retina………………………………………………………………………… 19 1.2 The G-protein-coupled receptor rhodopsin………………………………………… 19 1.2.1 Phototransduction……………………………………………………………………. 21 1.2.2 Light-regulated translocation of photoreceptor proteins…………………………….. 23 1.3 Cilia and ciliopathies…………………………………………………………………. 23 1.3.1 Cilia in vertebrate cells………………………………………………………………. 23 1.3.1.1 The photoreceptor connecting cilium……………………………………………… 24 1.3.2 Cilia-related disorders……………………………………………………………….. 26 1.3.2.1 Leber congenital amaurosis……………………………………………………….. 29 1.3.2.1.1 Lebercilin……………………………………………………………………… 30 Monika Beer, Dissertation Table of Contents 2. GTPASES………………………………………………………………………………… 30 2.1 GTP binding proteins in signal transduction………………………………………. 30 2.2 Rho family GTPases………………………………………………………………….. 31 2.2.1 Cell morphology……………………………………………………………………... 32 2.2.2 Cell movement………………………………………………………………………. 33 2.2.3 Cell behaviour……………………………………………………………………… 35 2.2.4 Post-translational C-terminal modifications of Rho GTPases………………………. 35 2.2.5 Regulation of Rho family GTPases………………………………………………… 36 2.2.6 Rho GTPases in the eye……………………………………………………………... 38 2.2.6.1 Rho GTPases in the retina………………………………………………………… 39 2.3.Collapsin response mediator proteins (CRMP)…………………………………….. 40 2.3.1 CRMP2 switches RhoA and Rac1 morphology……………………………………... 40 3. PHOSPHODIESTERASES AND PDEδ………………………………………………... 43 3.1 Phosphodiesterases…………………………………………………………………… 43 3.1.1 PDE6………………………………………………………………………………… 45 3.2 PDEδ………………………………………………………………………………… 45 3.2.1 PDEδ in the retina…………………………………………………………………… 46 3.2.2 Structure of PDEδ…………………………………………………………………… 46 3.2.3 PDEδ homologes…………………………………………………………………….. 48 E. AIM OF THE STUDY……………………………………………………... 51 F. MATERIAL AND METHODS……………………………………………. 54 1. MATERIAL………………………………………………………………………………. 54 1.1 Chemicals………………………………………………………………………………54 1.2 General equipment…………………………………………………………………… 54 1.3 Protein chemistry…………………………………………………………………….. 55 1.3.1 Special equipment…………………………………………………………………… 55 1.3.2 Kits…………………………………………………………………………………... 55 1.4 Molecular biology…………………………………………………………………….. 55 1.4.1 Special equipment…………………………………………………………………… 55 1.4.2 Kits…………………………………………………………………………………... 56 1.4.3 E. coli strains………………………………………………………………………… 56 1.4.4 Oligonucleotides……………………………………………………………………... 56 1.4.5 Plasmids and constructs……………………………………………………………... 57 Monika Beer, Dissertation Table of Contents 1.4.5.1 Plasmids…………………………………………………………………………… 57 1.4.5.2 Constructs………………………………………………………………..……….. 57 1.5 Mammalian cell and tissue culture………………………………………………….. 57 1.5.1 Special equipment…………………………………………………………………… 57 1.5.2 Kits…………………………………………………………………………………... 57 1.5.3 Mammalian cell lines………………………………………………………………... 58 1.5.4 Antibodies…………………………………………………………………………… 58 1.6 Software and databases……………………………………………………………… 60 1.6.1 Software……………………………………………………………………………... 60 1.6.2 Databases…………………………………………………………………………….. 61 2. METHODS……………………………………………………………………………….. 62 2.1 Protein chemistry…………………………………………………………………….. 62 2.1.1 Determination of protein concentration……………………………………………... 62 2.1.2 Protein precipitation…………………………………………………………………. 62 2.1.3 Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)……………………………………………………. 63 2.1.3.1 SDS-PAGE gradient gels………………………………………………………….. 65 2.1.3.1.1 Casting of SDS gradient mini gels with a gradient maker……………………. 65 2.1.3.2 Sample preparation………………………………………………………………... 65 2.1.4 Blue-native PAGE (BN-PAGE)……………………………………………………. 65 2.1.5 Second-dimensional gel electrophoresis (2-DE)…………………………………….. 68 2.1.5.1 Sample preparation………………………………………………………………... 69 2.1.5.2 Rehydration and sample loading…………………………………………………... 70 2.1.5.3 Isoelectric focusing (IEF)………………………………………………………….. 70 2.1.5.4 Equilibration and transfer of the IPG strips………………………………………. 70 2.1.5.5 Second dimension: SDS-PAGE……………………………………………………. 71 2.1.6 Staining of SDS gels………………………………………………………………… 71 2.1.6.1 Silver staining……………………………………………………………………… 71 2.1.6.2 Coomassie staining……………………………………………………………… 72 2.1.6.3 Digitalizing and drying of SDS gels……………………………………………..… 72 2.1.7 Western blot analysis………………………………………………………………... 73 2.1.7.1 Semi dry blotting…………………………………………………………………... 73 2.1.8 Analysis of protein interactions……………………………………………………… 75 Monika Beer, Dissertation Table of Contents 2.1.8.1 Immunoprecipitations from porcine retina………………………………………... 75 2.1.8.2 Immunoprecipitations from ROS…………………………………………………... 75 2.1.8.3 Rac1-GTP Pull Down……………………………………………………………… 76 2.1.8.4 Tandem affinity purification (TAP)………………………………………………... 76 2.1.8.4.1 Transfection of HEK293 cells transiently expressing the SF-TAP fusion protein……………………………………………………………… 77 2.1.8.4.2 SF-TAP purification protocol (Gloeckner in press)…………………………... 77 2.1.9 Mass spectrometry…………………………………………………………………… 78 2.1.9.1 In-gel proteolysis…………………………………………………………………... 79 2.1.9.1.1 In-gel proteolysis of silver-stained and Coomassie-stained gels………………………………………………………... 79 2.1.9.2 Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS)…………………………………………………... 79 2.1.9.3 Peptide mass finger printing (PMF) and tandem mass spectrometry (MS/MS)………………………………………………. 80 2.1.9.3.1 Mass measurement with the Applied Biosystems 4700 Proteomics Analyzer (AB4700)…………………………………………. 81 2.1.9.4 Electrospray ionization mass spectrometry (ESI-MS)…………………………….. 82 2.1.9.4.1 Mass measurement with the Q-TOF II ESI mass spectrometer………………. 82 2.1.9.4.2 Mass measurement with the LTQ OrbitrapXL mass spectrometer…………….83 2.1.9.5 Data processing and criteria for protein identification …………………………………………………………………. 84 2.2 Isolation of porcine rod outer segments…………………………………………….. 85 2.3 PDEδ subunit activity assay…………………………………………………………. 86 2.4 Light- dependent methylation of Rac1 in ROS and autoradiography………………………………...………………………………. 87 2.4.1 Immunoprecipitation of methylated Rac1…………………………………………… 87 2.4.2 Identification of methylated ROS proteins by mass spectrometry…………………... 88 2.5 Immunohistochemistry………………………………………………………………. 88 2.6 Molecular biology…………………………………………………………………….. 89 2.6.1 E. coli cultures……………………………………………………………………….. 89 2.6.1.1 Liquid cultures……………………………………………………………………... 89 2.6.1.2 Plating cultures……………………………………………………………………. 89 2.6.1.3 Cryo cultures………………………………………………………………………. 89 Monika Beer, Dissertation Table of Contents 2.6.1.4 Generation of chemically competent E. coli………………………………………. 89 2.6.2 Chemical transformation of E. coli………………………………………………….. 90 2.7.3 Plasmid DNA preparation…………………………………………………………… 90 2.6.4 DNA sequencing…………………………………………………………………….. 91 2.6.5 Agarose gel electrophoresis…………………………………………………………. 92 2.6.6 Polymerase chain reaction (PCR)…………………………………………………… 92 2.6.7 Gateway cloning……………………………………………………………………... 93 2.7 Establishment of an organotypical retinal explant system from murine retina…………………………………………………………………… 97 2.7.1 Culturing of retinal explants…………………………………………………………. 97 2.7.2 Analysis of explant cultures………………………………………………………. 100 2.7.2.1 Tissue analysis…………………………………………………………………... 100 2.7.2.2 Test for apoptosis - TUNEL assay……………………………………………… 100 2.8 Production of rat and mouse monoclonal CRMP2 specific antibodies…………………………………………………………. 102 2.8.1 Peptide selection……………………………………………………………………. 103 2.8.2 Antibody validation by Western blot………………………………………………. 106 2.8.3 Antibody validation by immunohistochemistry (IHC)…………………………….. 107 2.8.4 Antibody validation by immunoprecipitation............................................................ 107 G. RESULTS…………………………………………………………………. 108 1. ANALYSIS OF RHO GTPASES IN ROD OUTER SEGMENTS (ROS)……………………………………………………. 108 1.1 Identification of the Rac1 interactome in ROS…………………………………… 108 1.1.1 Establishment of the Rac1 IP from soluble and
Load more

Recommended publications
  • Reprogramming Metabolism by Targeting Sirtuin 6 Attenuates Retinal Degeneration
    The Journal of Clinical Investigation RESEARCH ARTICLE Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration Lijuan Zhang,1,2,3 Jianhai Du,4 Sally Justus,1,2 Chun-Wei Hsu,1,2 Luis Bonet-Ponce,5 Wen-Hsuan Wu,1,2 Yi-Ting Tsai,1,2 Wei-Pu Wu,1,2 Yading Jia,2 Jimmy K. Duong,6 Vinit B. Mahajan,7 Chyuan-Sheng Lin,8 Shuang Wang,6 James B. Hurley,4 and Stephen H. Tsang1,2,9 1The Jonas Children’s Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Department of Ophthalmology, Columbia University, New York, New York, USA. 2Edward S. Harkness Eye Institute, New York-Presbyterian Hospital, New York, New York, USA. 3Shanxi Eye Hospital, affiliated with Shanxi Medical University, Xinghualing, Taiyuan, China. 4Department of Biochemistry and Ophthalmology, University of Washington, Seattle, Washington, USA. 5Section on Retinal Ganglion Cell Biology, Laboratory of Retinal Cell and Molecular Biology, NIH, Bethesda, Maryland, USA. 6Department of Biostatistics, Mailman School of Public Health, Columbia University Medical Center, New York, New York, USA. 7Omics Lab, University of Iowa, Iowa City, Iowa, USA. 8Department of Pathology and Cell Biology, Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons of Columbia University, New York, New York, USA. 9Departments of Pathology and Cell Biology, Institute of Human Nutrition, College of Physicians and Surgeons, Columbia University, New York, New York, USA. Retinitis pigmentosa (RP) encompasses a diverse group of Mendelian disorders leading to progressive degeneration of rods and then cones. For reasons that remain unclear, diseased RP photoreceptors begin to deteriorate, eventually leading to cell death and, consequently, loss of vision.
    [Show full text]
  • Circulating Supar in Two Cohorts of Primary FSGS
    CLINICAL RESEARCH www.jasn.org Circulating suPAR in Two Cohorts of Primary FSGS † ‡ Changli Wei,* Howard Trachtman, Jing Li,* Chuanhui Dong, Aaron L. Friedman,§ | | | Jennifer J. Gassman, June L. McMahan, Milena Radeva, Karsten M. Heil,¶ †† ‡‡ Agnes Trautmann,¶ Ali Anarat,** Sevinc Emre, Gian M. Ghiggeri, Fatih Ozaltin,§§ || ††† Dieter Haffner, Debbie S. Gipson,¶¶ Frederick Kaskel,*** Dagmar-Christiane Fischer, ‡‡‡ Franz Schaefer,¶ and Jochen Reiser, for the PodoNet and FSGS CT Study Consortia Departments of *Medicine and ‡Neurology, University of Miami Miller School of Medicine, Miami, Florida; †Department of Pediatrics, NYU Langone Medical Center, New York, New York; §Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota; |Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio; ¶Center for Pediatric and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany; **Department of Pediatric Nephrology, Cukurova University School of Medicine, Adana, Turkey; ††Department of Pediatrics, Istanbul Medical Faculty, University of Istanbul, Istanbul, Turkey; ‡‡Division of Nephrology, Dialysis, and Transplantation, Laboratory on Pathophysiology of Uremia, G. Gaslini Children’s Hospital, Genoa, Italy; §§Pediatric Nephrology Unit, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey; ||Department of Pediatric Kidney, Liver, and Metabolic Diseases, Hannover Medical School, Hannover, Germany; ¶¶Department of Pediatrics, University of Michigan, Ann Arbor, Michigan; ***Children’s Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York; †††Department of Pediatrics, Rostock University Hospital, Rostock, Germany; and ‡‡‡Department of Medicine, Rush University Medical Center, Chicago, Illinois ABSTRACT Overexpression of soluble urokinase receptor (suPAR) causes pathology in animal models similar to pri- mary FSGS, and one recent study demonstrated elevated levels of serum suPAR in patients with the disease.
    [Show full text]
  • Impedes Transport of GRK1 and PDE6 Catalytic Subunits to Photoreceptor Outer Segments
    Deletion of PrBP/␦ impedes transport of GRK1 and PDE6 catalytic subunits to photoreceptor outer segments H. Zhang*, S. Li*, T. Doan†, F. Rieke†‡, P. B. Detwiler†, J. M. Frederick*, and W. Baehr*§¶ʈ *John A. Moran Eye Center, University of Utah Health Science Center, Salt Lake City, UT 84132; †Department of Physiology and Biophysics and ‡Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195; and Departments of §Neurobiology and Anatomy and ¶Biology, University of Utah, Salt Lake City, UT 84112 Edited by Jeremy Nathans, Johns Hopkins University School of Medicine, Baltimore, MD, and approved April 11, 2007 (received for review February 23, 2007) The mouse Pde6d gene encodes a ubiquitous prenyl binding chains (5, 7). Posttranslational sorting and targeting of proteins protein, termed PrBP/␦, of largely unknown physiological function. occurs in all cells and is of particular importance in photore- PrBP/␦ was originally identified as a putative rod cGMP phospho- ceptors, which renew their entire outer segments roughly every diesterase (PDE6) subunit in the retina, where it is relatively 10 days (8). Because of compartmentalization of inner and outer abundant. To investigate the consequences of Pde6d deletion in segments and very active metabolism, photoreceptors are re- .retina, we generated a Pde6d؊/؊ mouse by targeted recombina- garded as model cells to study protein trafficking tion. Although manifesting reduced body weight, the Pde6d؊/؊ PrBP/␦, originally thought to be a subunit of PDE6 and termed mouse was viable and fertile and its retina developed normally. PDE␦ (9), was shown recently to be a prenyl binding protein (10, Immunocytochemistry showed that farnesylated rhodopsin kinase 11) and subsequently named PrBP/␦ to reflect this fact (12).
    [Show full text]
  • Regulation of Calmodulin-Stimulated Cyclic Nucleotide Phosphodiesterase (PDE1): Review
    95-105 5/6/06 13:44 Page 95 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 18: 95-105, 2006 95 Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): Review RAJENDRA K. SHARMA, SHANKAR B. DAS, ASHAKUMARY LAKSHMIKUTTYAMMA, PONNIAH SELVAKUMAR and ANURAAG SHRIVASTAV Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan, Cancer Research Division, Saskatchewan Cancer Agency, 20 Campus Drive, Saskatoon SK S7N 4H4, Canada Received January 16, 2006; Accepted March 13, 2006 Abstract. The response of living cells to change in cell 6. Differential inhibition of PDE1 isozymes and its environment depends on the action of second messenger therapeutic applications molecules. The two second messenger molecules cAMP and 7. Role of proteolysis in regulating PDE1A2 Ca2+ regulate a large number of eukaryotic cellular events. 8. Role of PDE1A1 in ischemic-reperfused heart Calmodulin-stimulated cyclic nucleotide phosphodiesterase 9. Conclusion (PDE1) is one of the key enzymes involved in the complex interaction between cAMP and Ca2+ second messenger systems. Some PDE1 isozymes have similar kinetic and 1. Introduction immunological properties but are differentially regulated by Ca2+ and calmodulin. Accumulating evidence suggests that the A variety of cellular activities are regulated through mech- activity of PDE1 is selectively regulated by cross-talk between anisms controlling the level of cyclic nucleotides. These Ca2+ and cAMP signalling pathways. These isozymes are mechanisms include synthesis, degradation, efflux and seque- also further distinguished by various pharmacological agents. stration of cyclic adenosine 3':5'-monophosphate (cAMP) and We have demonstrated a potentially novel regulation of PDE1 cyclic guanosine 3':5'- monophosphate (cGMP) within the by calpain.
    [Show full text]
  • G Protein Regulation of MAPK Networks
    Oncogene (2007) 26, 3122–3142 & 2007 Nature Publishing Group All rights reserved 0950-9232/07 $30.00 www.nature.com/onc REVIEW G Protein regulation of MAPK networks ZG Goldsmith and DN Dhanasekaran Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA, USA G proteins provide signal-coupling mechanisms to hepta- the a-subunits has been used as a basis for the helical cell surface receptors and are criticallyinvolved classification of G proteins into Gs,Gi,Gq and G12 in the regulation of different mitogen-activated protein families in which the a-subunits that show more than kinase (MAPK) networks. The four classes of G proteins, 50% homology are grouped together (Simon et al., defined bythe G s,Gi,Gq and G12 families, regulate 1991). In G-protein-coupled receptor (GPCR)-mediated ERK1/2, JNK, p38MAPK, ERK5 and ERK6 modules by signaling pathways, ligand-activated receptors catalyse different mechanisms. The a- as well as bc-subunits are the exchange of the bound GDP to GTP in the a-subunit involved in the regulation of these MAPK modules in a following which the GTP-bound a-subunit disassociate context-specific manner. While the a- and bc-subunits from the receptor as well as the bg-subunit. The GTP- primarilyregulate the MAPK pathwaysvia their respec- bound a-subunit and the bg-subunit stimulate distinct tive effector-mediated signaling pathways, recent studies downstream effectors including enzymes, ion channels have unraveled several novel signaling intermediates and small GTPase, thus regulating multiple signaling including receptor tyrosine kinases and small GTPases pathways including those involved in the activation of through which these G-protein subunits positivelyas well mitogen-activated protein kinase (MAPK) modules as negativelyregulate specific MAPK modules.
    [Show full text]
  • It Takes Two Transducins to Activate the Cgmp-Phosphodiesterase 6 in Retinal Rods Rsob.Royalsocietypublishing.Org Bilal M
    It takes two transducins to activate the cGMP-phosphodiesterase 6 in retinal rods rsob.royalsocietypublishing.org Bilal M. Qureshi1,†,‡, Elmar Behrmann1,†,}, Johannes Scho¨neberg2,jj, Justus Loerke1,Jo¨rg Bu¨rger1, Thorsten Mielke1,3, Jan Giesebrecht1,§, Frank Noe´2, Trevor D. Lamb4, Klaus Peter Hofmann1,5, Christian M. T. Spahn1 and Martin Heck1 Research 1Institut fu¨r Medizinische Physik und Biophysik, Charite´ – Universita¨tsmedizin Berlin, corporate member Cite this article: Qureshi BM et al. 2018 It of Freie Universita¨t Berlin, Humboldt-Universita¨t zu Berlin, and Berlin Institute of Health, Berlin, Germany 2Department of Mathematics, Computer Science and Bioinformatics, Freie Universita¨t Berlin, Berlin, Germany takes two transducins to activate the cGMP- 3Microscopy and Cryo Electron Microscopy Group, Max-Planck Institut fu¨r Molekulare Genetik, Berlin, Germany phosphodiesterase 6 in retinal rods. Open Biol. 4Eccles Institute of Neuroscience, John Curtin School of Medical Research, Australian National University, 8: 180075. Canberra, Australian Capital Territory 2600, Australia 5 http://dx.doi.org/10.1098/rsob.180075 Zentrum fu¨r Biophysik und Bioinformatik, Humboldt-Universita¨t zu Berlin, Berlin, Germany BMQ, 0000-0002-0153-7729; TDL, 0000-0003-0299-6115; MH, 0000-0003-0847-5038 Received: 28 April 2018 Accepted: 6 July 2018 Among cyclic nucleotide phosphodiesterases (PDEs), PDE6 is unique in serving as an effector enzyme in G protein-coupled signal transduction. In Subject Area: retinal rods and cones, PDE6 is membrane-bound and activated to hydrolyse biochemistry/biophysics/structural biology its substrate, cGMP, by binding of two active G protein a-subunits (Ga*). To investigate the activation mechanism of mammalian rod PDE6, we Keywords: have collected functional and structural data, and analysed them by reac- PDE6, visual signal transduction, coincidence tion–diffusion simulations.
    [Show full text]
  • Genetic Variation in Phosphodiesterase (PDE) 7B in Chronic Lymphocytic Leukemia: Overview of Genetic Variants of Cyclic Nucleotide Pdes in Human Disease
    Journal of Human Genetics (2011) 56, 676–681 & 2011 The Japan Society of Human Genetics All rights reserved 1434-5161/11 $32.00 www.nature.com/jhg ORIGINAL ARTICLE Genetic variation in phosphodiesterase (PDE) 7B in chronic lymphocytic leukemia: overview of genetic variants of cyclic nucleotide PDEs in human disease Ana M Peiro´ 1,2, Chih-Min Tang1, Fiona Murray1,3, Lingzhi Zhang1, Loren M Brown1, Daisy Chou1, Laura Rassenti4, Thomas A Kipps3,4 and Paul A Insel1,3,4 Expression of cyclic adenosine monophosphate-specific phosphodiesterase 7B (PDE7B) mRNA is increased in patients with chronic lymphocytic leukemia (CLL), thus suggesting that variation may occur in the PDE7B gene in CLL. As genetic variation in other PDE family members has been shown to associate with numerous clinical disorders (reviewed in this manuscript), we sought to identify single-nucleotide polymorphisms (SNPs) in the PDE7B gene promoter and coding region of 93 control subjects and 154 CLL patients. We found that the PDE7B gene has a 5¢ non-coding region SNP À347C4T that occurs with similar frequency in CLL patients (1.9%) and controls (2.7%). Tested in vitro, À347C4T has less promoter activity than a wild-type construct. The low frequency of this 5¢ untranslated region variant indicates that it does not explain the higher PDE7B expression in patients with CLL but it has the potential to influence other settings that involve a role for PDE7B. Journal of Human Genetics (2011) 56, 676–681; doi:10.1038/jhg.2011.80; published online 28 July 2011 Keywords: cAMP; chronic lymphocytic
    [Show full text]
  • G Protein-Coupled Receptors
    www.aladdin-e.com Address:800 S Wineville Avenue, Ontario, CA 91761,USA Website:www.aladdin-e.com Email USA: [email protected] Email EU: [email protected] Email Asia Pacific: [email protected] G PROTEIN-COUPLED RECEPTORS Overview: The completion of the Human Genome Project allowed the identification of a large family of proteins with a common motif of seven groups of 20–24 hydrophobic amino acids arranged as a-helices. Approximately 800 of these seven transmembrane (7TM) receptors have been identified of which over 300 are non-olfactory receptors (see Fredriksson et al., 2003; Lagerstrom and Schioth, 2008). Subdivision on the basis of sequence homology allows the definition of rhodopsin, secretin, adhesion, glutamate and Frizzled receptor families. NC-IUPHAR recognizes Classes A, B, and C, which equate to the rhodopsin, secretin, and glutamate receptor families. The nomenclature of 7TM receptors is commonly used interchangeably with G protein-coupled receptors (GPCR), although the former nomenclature recognises signalling of 7TM receptors through pathways not involving G proteins. For example, adiponectin and membrane progestin receptors have some sequence homology to 7TM receptors but signal independently of G proteins and appear to reside in membranes in an inverted fashion compared to conventional GPCR. Additionally, the NPR-C natriuretic peptide receptor (see Page S195) has a single transmembrane domain structure, but appears to couple to G proteins to generate cellular responses. The 300+ non-olfactory GPCR are the targets for the majority of drugs in clinical usage (Overington et al., 2006), although only a minority of these receptors are exploited therapeutically.
    [Show full text]
  • (Gefs & Gaps) of the Rho Family
    Structural and biochemical investigation of the activity, specificity and regulation of regulators (GEFs & GAPs) of the Rho family Inaugural-Dissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultät der Heinrich-Heine-Universität Düsseldorf vorgelegt von Mamta Jaiswal aus Indien Düsseldorf, November 2012 Aus dem Institut für Biochemie und Molekularbiologie II der Heinrich-Heine-Universität Düsseldorf Gedruckt mit der Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der Heinrich-Heine-Universität Düsseldorf Referent: PD. Dr. Reza Ahmadian Koreferent: Prof. Dr. Dieter Willbold Tag der mündlichen Prüfung: 23.01.2013 Eidesstattliche Erklärung Hiermit erkläre ich an Eides statt, dass ich die hier vorgelegte Dissertation eigenständig und ohne unerlaubte Hilfe angefertigt habe. Es wurden keinerlei andere Quellen und Hilfsmittel, außer den angegebenen, benutzt. Zitate aus anderen Arbeiten wurden kenntlich gemacht. Diese Dissertation wurde in der vorgelegten oder einer ähnlichen Form noch bei keiner anderen Institution eingereicht und es wurden bisher keine erfolglosen Promotionsversuche von mir unternommen. Düsseldorf, im November 2012 To my family Table of Contents Table of Contents TABLE OF CONTENTS .................................................................................................. I TABLE OF FIGURES .................................................................................................... III PUBLICATIONS ...........................................................................................................
    [Show full text]
  • University of Cincinnati
    UNIVERSITY OF CINCINNATI Date: 1-Oct-2010 I, Jason Matthew Puglise , hereby submit this original work as part of the requirements for the degree of: Doctor of Philosophy in Cell & Molecular Biology It is entitled: Roles of the Rac/Cdc42 effector proteins Pak and PIX in cytokinesis, ciliogenesis, and cyst formation in renal epithelial cells Student Signature: Jason Matthew Puglise This work and its defense approved by: Committee Chair: Robert Brackenbury, PhD Robert Brackenbury, PhD 11/1/2010 1,117 Roles of the Rac/Cdc42 effector proteins Pak and PIX in cytokinesis, ciliogenesis, and cyst formation in renal epithelial cells A dissertation submitted to the Graduate School of the University of Cincinnati in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate Program of Cancer and Cell Biology of the College of Medicine by Jason M. Puglise M.Sc., Wright State University 2005 Committee Chair: Robert Brackenbury, Ph.D. ii ABSTRACT Puglise, Jason M. Ph.D., Cancer and Cell Biology Program. University of Cincinnati, 2010. Roles of the Rac/Cdc42 effector proteins Pak and PIX in cytokinesis, ciliogenesis, and cyst formation in renal epithelial cells. The p21-activated kinase 1 (Pak1) is a putative Rac/Cdc42 effector molecule and a multifunctional enzyme implicated in a wide range of cellular and biological activities. Although well-established as a regulator of cytoskeletal and microtubule dynamics, Pak1 influences centrosome behavior and plays a part in the cell cycle. We examine the role Pak1 and its binding partner Pak1-interacting exchange factor (PIX) play in centrosome dynamics and in cell cycle events in renal epithelial cells.
    [Show full text]
  • The Role of the Rho Gtpases in Neuronal Development
    Downloaded from genesdev.cshlp.org on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW The role of the Rho GTPases in neuronal development Eve-Ellen Govek,1,2, Sarah E. Newey,1 and Linda Van Aelst1,2,3 1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 11724, USA; 2Molecular and Cellular Biology Program, State University of New York at Stony Brook, Stony Brook, New York, 11794, USA Our brain serves as a center for cognitive function and and an inactive GDP-bound state. Their activity is de- neurons within the brain relay and store information termined by the ratio of GTP to GDP in the cell and can about our surroundings and experiences. Modulation of be influenced by a number of different regulatory mol- this complex neuronal circuitry allows us to process that ecules. Guanine nucleotide exchange factors (GEFs) ac- information and respond appropriately. Proper develop- tivate GTPases by enhancing the exchange of bound ment of neurons is therefore vital to the mental health of GDP for GTP (Schmidt and Hall 2002); GTPase activat- an individual, and perturbations in their signaling or ing proteins (GAPs) act as negative regulators of GTPases morphology are likely to result in cognitive impairment. by enhancing the intrinsic rate of GTP hydrolysis of a The development of a neuron requires a series of steps GTPase (Bernards 2003; Bernards and Settleman 2004); that begins with migration from its birth place and ini- and guanine nucleotide dissociation inhibitors (GDIs) tiation of process outgrowth, and ultimately leads to dif- prevent exchange of GDP for GTP and also inhibit the ferentiation and the formation of connections that allow intrinsic GTPase activity of GTP-bound GTPases (Zalc- it to communicate with appropriate targets.
    [Show full text]
  • Kinase-Inactive ZAP-70 Thymocyte Development By
    An Improved Retroviral Gene Transfer Technique Demonstrates Inhibition of CD4− CD8− Thymocyte Development by Kinase-Inactive ZAP-70 This information is current as of September 23, 2021. Takehiko Sugawara, Vincenzo Di Bartolo, Tadaaki Miyazaki, Hiromitsu Nakauchi, Oreste Acuto and Yousuke Takahama J Immunol 1998; 161:2888-2894; ; http://www.jimmunol.org/content/161/6/2888 Downloaded from References This article cites 49 articles, 28 of which you can access for free at: http://www.jimmunol.org/content/161/6/2888.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 23, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 1998 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. An Improved Retroviral Gene Transfer Technique Demonstrates Inhibition of CD42CD82 Thymocyte Development by Kinase-Inactive ZAP-701 Takehiko Sugawara,* Vincenzo Di Bartolo,§ Tadaaki Miyazaki,‡ Hiromitsu Nakauchi,* Oreste Acuto,§ and Yousuke Takahama2*† ZAP-70 is a Syk family tyrosine kinase that plays an essential role in initiating TCR signals.
    [Show full text]